ANI Pharmaceuticals Inc. (ANIP)
NASDAQ: ANIP
· Real-Time Price · USD
94.79
2.84 (3.09%)
At close: Oct 17, 2025, 3:59 PM
94.79
0.00%
After-hours: Oct 17, 2025, 04:31 PM EDT
ANI Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 614.38M | 486.82M | 316.38M | 216.14M |
Cost of Revenue | 250.21M | 181.51M | 138.78M | 100.61M |
Gross Profit | 364.17M | 305.3M | 177.6M | 115.53M |
Operating Income | 584K | 46.97M | -35.28M | -39.79M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -22.21M | 19.87M | -62.66M | -56.06M |
Net Income | -18.52M | 18.78M | -47.9M | -42.6M |
Selling & General & Admin | 249.64M | 161.7M | 124.04M | 84.29M |
Research & Development | 44.58M | 34.29M | 22.32M | 11.37M |
Other Expenses | 69.36M | 62.35M | 56.97M | 59.66M |
Operating Expenses | 363.58M | 258.33M | 203.33M | 155.32M |
Interest Expense | 17.6M | 26.94M | 28.05M | 11.92M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 613.79M | 439.85M | 351.67M | 255.93M |
Income Tax Expense | -3.69M | 1.09M | -14.77M | -13.46M |
Shares Outstanding (Basic) | 19.32M | 18M | 16.26M | 12.6M |
Shares Outstanding (Diluted) | 19.32M | 18.19M | 16.26M | 12.6M |
EPS (Basic) | -1.04 | 0.95 | -3.05 | -3.4 |
EPS (Diluted) | -1.04 | 0.94 | -3.05 | -3.4 |
EBITDA | 79.15M | 106.6M | 33.92M | -1.68M |
EBIT | 11.42M | 46.81M | -36.91M | -48.94M |
Depreciation & Amortization | 67.73M | 59.79M | 59.65M | 47.25M |
Source: Financial Modeling Prep. Financial Sources.